iSpeak Blog
Josef Trapl
Memo3 GmbH
Managing Director
Josef Trapl holds a MSc. in Chemical Engineering from TU Granz Austria, and an MBA from Mannheim Business School, Germany. In his professional career he gained expertise as Construction Manager and Global Technology Manager at M+W Group. In 2014 he co-founded Memo3 GmbH. From 2015-2023 he worked as Global Head of MSci Innovation, within the Global Manufacturing Supply Organization (GMS) at Takeda Pharmaceuticals International. Since 2023 he is Managing director of Memo3 GmbH.
Josef Trapl passionately drives innovation in manufacturing. He has extensive global design and project experience across several business areas in the Life Science Industry including Biotech, Stem Cell, Fill & Finish, Oral Solid Dosage (OSD) production. He holds high expertise in industry trends, new technologies, automation solutions, technology transfer, regulatory and GMP aspects.
Since 2010, Josef is an active member of the ISPE. As core team member, he was involved in the Sustainability Handbook published in 2015. In 2022 he organized the ISPE Pharma 4.0™ DACH Emerging Leader Hackathon. Currently he is member of the CoP Pharma 4.0™ leadership team and co-leads the Pharma 4.0 Plug and Produce working group.
Josef Trapl passionately drives innovation in manufacturing. He has extensive global design and project experience across several business areas in the Life Science Industry including Biotech, Stem Cell, Fill & Finish, Oral Solid Dosage (OSD) production. He holds high expertise in industry trends, new technologies, automation solutions, technology transfer, regulatory and GMP aspects.
Since 2010, Josef is an active member of the ISPE. As core team member, he was involved in the Sustainability Handbook published in 2015. In 2022 he organized the ISPE Pharma 4.0™ DACH Emerging Leader Hackathon. Currently he is member of the CoP Pharma 4.0™ leadership team and co-leads the Pharma 4.0 Plug and Produce working group.
Related Articles
Online Exclusives
Innovation is an integral part of corporate strategy. Initiatives to facilitate innovation are continually developed and pursued. The 2022 ISPE Pharma 4.0™ Emerging Leader (EL) Hackathon was designed based on innovator needs and provided a hands-on blueprint manufacturing exercise. Over a period of two days and facilitated by 40 subject matter experts, coaches, and jury members, 50...
iSpeak Blog
The 2022 ISPE Pharma 4.0™ Emerging Leader Hackathon event was organized by the ISPE Emerging Leaders DACH Affiliate in collaboration with the ISPE Pharma 4.0™ Community of Practice (CoP) Plug and Produce Subcommittee. The goal was to bring together students and young professionals from different fields of study and countries together to explore the emerging challenges and opportunities in...
iSpeak Blog
ISPE’s Pharma 4.0™ initiative provides guidance, aligned with the regulatory requirements specific to the pharmaceutical industry, to accelerate Pharma 4.0™ transformations. Also known as the Smart Factory, the objective of Pharma 4.0 is to enable organizations involved in the product lifecycle to leverage the full potential of digitalization to provide faster innovations for the benefit of...